HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens
FALLS CHURCH, Va., June 22 /PRNewswire-USNewswire/ -- With today's announcement that the Pharmaceutical Research and Manufacturers of America (PhRMA) has offered to voluntarily grant some $80 billion in discounts to Medicare beneficiaries over the next decade in an effort to reduce overall healthc...
Ipsogen Expands its US Market Presence Through Licensing Agreement With ARUP Laboratories for the Commercialization of JAK2 Molecular Diagnostic Assays
MARSEILLE, France, May 4 /PRNewswire-FirstCall/ -- Ipsogen SA (Alternext
- FR0010626028 - ALIPS), a molecular diagnostic company specialized in the
development, the manufacturing and the commercialization of diagnostic assays
for breast cancer and leukemia, today announces the signature of an ...
New Study Suggests Rx Estrogen Delivery Through the Skin May Show Safety Benefits as Opposed to Oral Delivery
NEW YORK, March 31 /PRNewswire/ -- Transdermal delivery of estrogen therapy available by prescription "seems not to alter" the risk of venous thromboembolism (VTE), or blood clotting, in postmenopausal patients when compared to oral delivery, a new study suggests. The study was conducted by res...
Gallbladder Removal Through Vagina Offers Minimally Invasive Alternative
Physicians at Northwestern Memorial are among the first groups in the U.S. to successfully complete vaginal natural orifice translumenal endoscopic surgery or NOTES
CHICAGO, Feb. 25 /PRNewswire-USNewswire/ -- Physicians at Northwestern Memorial Hospital successfully removed a patient's...
Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
SAN DIEGO, Feb. 24 /PRNewswire/ -- Ambrx Inc, and Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced a global strategic collaboration to develop and commercialize Ambrx's ARX424 preclinical product candidate for the treatment of multiple sclerosis. ARX424 was created by A...
Phico Therapeutics Receives GBP1 Million Award From the Wellcome Trust to Take Anti-MRSA Nasal Product Through Early Clinical Trials
CAMBRIDGE, England, January 28 /PRNewswire/ -- Phico Therapeutics today
announced it has been granted a Wellcome Trust Strategic Translational Award
totalling GBP1.03 million to cover Phase I and II trials of its lead
candidate SASPject(TM) PT1.2 for nasal decolonisation of MRSA and S. aureus....
Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3
CAMBRIDGE, Mass., Oct. 1 /PRNewswire/ -- Ironwood Pharmaceuticals, Inc.
today announced it has raised $50 million in a private equity financing.
This capital will be utilized to support the ongoing Phase 3 development
program evaluating linaclotide for the treatment of irritable bowel
Unprecedented 8th Year Start Up of National Direct AmeriCorps Program Access to Care Through Service (ACTS) Parent, Lead Organization The Philadelphia AIDS Consortium and World Health Care Infrastructures
PHILADELPHIA, Sept. 30 /PRNewswire-USNewswire/ -- The following is
being released by The Philadelphia AIDS Consortium:
WHO: Parent Organization: The Philadelphia AIDS Consortium in
partnership with its network of eleven (11) community-based organization
sites located throughout the tri-state...
DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix(TM) or Aspirin
REYKJAVIK, Iceland, June 30 /PRNewswire-FirstCall/ -- deCODE genetics
(Nasdaq: DCGN ) today announced positive topline results from its latest
clinical pharmacology study of DG041, the company's first-in-class
antagonist of the EP3 receptor for prostaglandin E2, developed as a
BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment
Pioneering firm marks milestone with initiatives aimed at knowledge transfer, including landmark medical research collaboration between Massachusetts and the Italian government in Lombardia
NEWTON, Mass., June 25 /PRNewswire/ -- BBK Worldwide, an innovator and
leader in global patie...
TorreyPines Therapeutics to Host Webinar at 11 a.m. EDT Today on the Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate
TorreyPines Therapeutics' CEO Neil Kurtz, M.D., to Moderate Discussion
Following Presentations by Tony Yaksh, Ph.D.; Jerome Goldstein, M.D.; and Alan J. Tuchman, M.D.
LA JOLLA, Calif., June 25 /PRNewswire/ -- A Webinar hosted by
TorreyPines Therapeutics, Inc. (Nasdaq:...
DaVita Strives to Improve Quality of Life and Reduce Overall Costs of Kidney Care Through Community-Based Education
EL SEGUNDO, Calif., June 23 /PRNewswire/ -- DaVita Inc., a leading
provider of kidney care services for those diagnosed with chronic kidney
failure and disease (CKD), recently introduced its EMPOWER program, a
series of free community-based workshops that encourage CKD patients to
Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation
LOS ANGELES, California, June 18 /PRNewswire-FirstCall/ -- Canopus
BioPharma, Inc. (OTC: CBIA), a biotechnology company developing
pharmaceutical products and assay methods for patients suffering from
infectious disease, radiation sickness, cancer and addiction, today
announced the signing of ...
Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
ST. LOUIS, June 11 /PRNewswire/ -- Orion Genomics announced today that
the company entered into a worldwide exclusive license agreement with The
Johns Hopkins University (JHU) to commercialize products that identify
patients at risk for colorectal cancer. The license is based on a suite of
EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
Selective Kinase Inhibitor Phase 1 Trial in Advanced Cancer Patients
ROCKVILLE, Md., April 9, 2008 /PRNewswire-FirstCall/ -- EntreMed, Inc.
(Nasdaq: ENMD ), a clinical-stage pharmaceutical company developing
therapeutics for the treatment of cancer and inflammatory diseases, today
BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients
- Data Indicate Pre-existing Lamivudine Resistance Predisposes Patients to Higher Rates of BARACLUDE Resistance -
PRINCETON, N.J., March 24 /PRNewswire-FirstCall/ -- New BARACLUDE(R)
(entecavir) data presented today demonstrated a continued low incidence of
resistance in nucleos...
IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study
IRVINE, Calif., March 20 /PRNewswire-FirstCall/ -- IDM Pharma, Inc.
(the Company) (Nasdaq: IDMI ) announced today that it has initiated
enrollment in a clinical protocol finalized with the U.S. Food and Drug
Administration (FDA), which provides mifamurtide (L-MTP-PE) to eligible,
AGI Dermatics Clinical Data Indicate Bicyclic Monoterpene Diols Suppress MMP1 and Stimulate Collagen Through TNF-a Signaling
Clinical Data Presented at the 66th Annual Meeting of the American Academy of Dermatology
FREEPORT, N.Y., Feb. 11 /PRNewswire/ -- AGI Dermatics clinical research
indicates that the ability of bicyclic monoterpene diols (BMTds) to reduce
collagenese MMP-1 secretion an...
One Shot of Gene Therapy Spreads Through Brain in Animal Study
- Method Has Potential for Correcting Devastating Genetic Diseases -
PHILADELPHIA, Oct. 8 /PRNewswire-USNewswire/ -- By targeting a site in
a mouse brain well connected to other areas, researchers successfully
delivered a beneficial gene to the entire brain -- after one injection of
Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
Phase 2 Clinical Trial Initiated for a p38 Kinase Inhibitor Identified through
Collaboration with Bristol-Myers Squibb for the Treatment of Psoriasis
PRINCETON, N.J., Sept. 18 /PRNewswire-FirstCall/ -- Pharmacopeia
(Nasdaq: PCOP ), an innovator in the discovery...
WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals' CEO
NEW YORK, Aug. 8 /PRNewswire-FirstCall/ -- On August 7, J. J.
Finkelstein, Chief Executive Officer of RegeneRx Biopharmaceuticals (Amex:
RGN) updated the investment community in an all-new interview with
http://www.wallst.net . Topics covered in the interview include RegeneRx
Novel Technology Breaks Through Cancer Pain
MORRISVILLE, N.C., Aug. 16 /PRNewswire/ -- Cancer patients fraught with
flare-ups of pain, or breakthrough pain, may soon receive some assistance
in the form of a new easy-to-use oral drug delivery system developed by
BioDelivery Sciences designed to quickly deliver pain medication. Cancer pa...
Long-Term Extension of Ulcerative Colitis Study Shows Remicade
Responders Maintained Improvement Through Two Years of Follow-Up
Separate Survey Underscores Impact of Disease on Work Status and
WASHINGTON, May 23, 2007 /PRNewswire-FirstCall/ -- Findings
presented today at Digestive Disease Week(R) 2007 (DDW), from
long-term extensions of the ACT trials (Active Ulcerative Colitis 1
& 2) show that subjects wi...
Clinical Trial Excellence: Shaping Markets Through Early
Communication of Clinical Trial Data
CHAPEL HILL, N.C., May 25, 2007 /PRNewswire/ -- With enormous
investments and the success of a pharmaceutical product at play,
pharmaceutical firms need to develop effective strategies for
communicating clinical trial results early. Companies that master
their communication planning and execution ...
Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases
...r of the eye. The tiny cup administers the drug slowly by passive diffusion through
the sclera, where it reaches the retina and vitreous. The device is so smal...ion.
Currently, drugs for most retinal diseases are delivered either through
an I.V. drip (i.e. systemically) or by an injection into the eyeball (i.e. ...
Regular Yoga Practice Is Associated With Mindful Eating
... not. This was independent of physical activity and dietary patterns. We hypothesized that mindfulness - a skill learned either directly or indirectly through
yoga -could affect eating behavior," said Kristal, associate head of the Cancer Prevention Program in the Public Health Sciences Division at the Hutch...
Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
...by new clinical data, immunogenicity and safety data will be made available through
clinical studies. Sanofi Pasteur will test the immunogenicity and safety of its influenza A(H1N1) 2009 monovalent vaccine through
clinical trials in the U.S., which began August 6. The planned clinical tri...
Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer
...n important role in cell growth regulation. In mCRC, EGFR transmits signals through
a set of intracellular proteins. Upon reaching the nucleus, these signals i...lar variability in the future. We develop product candidates internally and through
licensing collaborations, partnerships and joint ventures. Product candida...
Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
...eries are being translated into human therapeutics through
an internal preclinical drug discovery effort coup...Novartis. Founded in 1999, the Institute is funded through
the Novartis Research Foundation.
About JD... to find a cure for diabetes and its complications through
the support of research. Type 1 diabetes is a dise...
Cancer Centers of North Carolina Offers HDR Brachytherapy for Treatment of Cancerous Tumors
..., Inc. , continues to offer cutting-edge treatment options to its patients through
the addition of High Dose Rate (HDR) brachytherapy. This latest advance in ...ith HDR brachytherapy, radiation is delivered directly to the cancer target through
the use of catheters, needles or applicators inserted into a body cavity or...
Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis
...n bone metabolism, PTHrP (parathyroid hormone-related protein) and its analogs are critical peptides for promoting new bone formation. Though they act through
the same receptor, PTHrP and its analogs play a distinct biological role from the PTH (parathyroid hormone) peptide by activating different signaling ...
NewCardio Announces Master Services Agreement With Dedicated Phase I
...s part of a transition from semi-automated methods to more advanced, higher quality, and more efficient methodologies made possible for the first time through
the use of NewCardio's QTinno(TM) solution.
NewCardio's innovative 3D ECG platform technology dramatically improves the accuracy and significan...
NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone
...t from drug candidates in development by other companies with greater resources and visibility; our ability to obtain adequate financing in the future through
product licensing, public or private equity or debt financing or otherwise; general business conditions; competition; business abilities and judgment ...
2,500 Cases Completed With the Magnetic Irrigated Catheter
...tem is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through
the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that go...
Nektar Therapeutics Reports Second Quarter 2009 Financial Results
Passcode: 25099763 (Howard Robin is the host)
An audio replay will also be available shortly following the call through
Wednesday, August 19, 2009 and can be accessed by dialing (888) 286-8010 (U.S.); or (617) 801-6888 (international) with a passcode of 26851386.
DNA Helps Reunite Children With Their Families
... , is on a mission to stop this horrific industry through
a $500,000 grant from The Life Technologies Foun...d and homeless children with their parents.
the DNA-PROKIDS program, DNA samples will be obtai...children associated with human trafficking whether through
prostitution, forced labor, militant activities, o...
Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
...ry approval for product marketing has in the past varied and we expect similar variability in the future. We develop product candidates internally and through
licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between...
Project Zero Delay Accelerates Drug's Path to Clinical Trial
...n as quickly as in a day.
"Zero Delay demonstrates what can be accomplished in an atmosphere of trust and collaboration that we've cultivated through
our strategic alliance," Bast said. The alliance agreement also includes a commitment to regular meetings, a point of contact to remove obstacles, sup...
TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men
...rticularly interesting because the effects of GH therapy have not been studied extensively. The body naturally secretes growth hormones to fuel growth through
childhood and maintain tissues and organs. Their use as an anti-aging therapy stems from the natural decrease of growth hormones secreted by the body ...
Society of Gynecologic Oncologists Issues White Paper on HPV Vaccine's Impact on Cervical Cancer Prevention
...ding the limits of current screening, the impact that eliminating HPV 16/18 through
vaccination may have on rates of cervical precancer and cervical cancer scr...ening
"The information garnered from this meeting and shared through
this series of white papers will serve as an invaluable tool to our colleag...